Stocksigma LogoStocksigma Logo

Sahajanand Medical Technologies Reports Strong Q2 and H1 FY27 Performance

In its first results post-listing on 23rd Oct'26, Sahajanand Medical Technologies delivered record Q2 FY27 performance, with revenue rising 24.7% YoY to

Sahajanand Medical Technologies Reports Strong Q2 and H1 FY27 Performance

Sahajanand Medical Technologies Limited · Investor Presentation · 05 Nov 2026, 10:51 pm

Sahajanand Medical Technologies Reports Strong Q2 and H1 FY27 Performance In its first results post-listing on 23rd Oct'26, Sahajanand Medical Technologies delivered record Q2 FY27 performance, with revenue rising 24.7% YoY to ₹3,734 mn, EBITDA increasing 36.6% YoY to ₹656 mn (margin at 17.6%), and PAT growing 26.6% YoY to ₹265 mn. For H1 FY27, revenue expanded 24.9% YoY to ₹7,251 mn, driven by 37.1% YoY growth in RoW markets. Annualised ROCE and ROE improved to 16.7% and 11.2%, respectively, while the cash conversion cycle shortened by 10 days YoY to 128 days.

Original exchange filing (PDF)

More announcements from Sahajanand Medical Technologies Limited

All Sahajanand Medical Technologies Limited announcements